SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?


To: Richard Haugland who wrote (181)4/16/1998 8:45:00 AM
From: Richard Haugland  Read Replies (1) | Respond to of 3044
 
Millennium Pharmaceuticals, Inc. Identifies Key Mechanism For Regulating Plasma Levels of HDL or 'Good' Cholesterol

Report in PNAS Validates SR-BI Receptor As Key Molecule in Liver Uptake of HDL; Potential As Novel Drug Target for Treating Heart Disease

biz.yahoo.com

Hopefully this announcement will generate more sustained interest in this company and its stock than did yesterday's. It is good to have the company putting out some positive information, at least.